| 臺大學術典藏 |
2022-02-18T08:47:00Z |
Transnasal endoscopy with narrow-band imaging and Lugol staining to screen patients with head and neck cancer whose condition limits oral intubation with standard endoscope (with video)
|
Lee Y.-C.; Wang C.-P.; CHIEN-CHUAN CHEN; Chiu H.-M.; Ko J.-Y.; Lou P.-J.; Yang T.-L.; Huang H.-Y.; Wu M.-S.; Lin J.-T.; Hsiu-Hsi Chen T.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-18T08:46:59Z |
Performance of narrow band imaging and magnification endoscopy in the prediction of therapeutic response in patients with gastroesophageal reflux disease
|
Tseng P.-H.; CHIEN-CHUAN CHEN; Chiu H.-M.; Liao W.-C.; Wu M.-S.; Lin J.-T.; Lee Y.-C.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-18T08:46:59Z |
Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: A randomised comparative trial with crossover design
|
Liou J.-M.; Lin J.-T.; Chang C.-Y.; Chen M.-J.; Cheng T.-Y.; Lee Y.-C.; CHIEN-CHUAN CHEN; Sheng W.-H.; Wang H.-P.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:58Z |
Association of diabetes and HbA 1c levels with gastrointestinal manifestations
|
Tseng P.-H.; Lee Y.-C.; Chiu H.-M.; CHIEN-CHUAN CHEN; Liao W.-C.; Tu C.-H.; Yang W.-S.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:57Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEN-CHUAN CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-18T08:46:57Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chen M.-J.; CHIEN-CHUAN CHEN; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:56Z |
Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions
|
Lee Y.-C.; Chiu H.-M.; Chiang T.-H.; Yen A.M.-F.; Chiu S.Y.-H.; Chen S.L.-S.; Fann J.C.-Y.; Yeh Y.-P.; Liao C.-S.; Hu T.-H.; Tu C.-H.; Tseng P.-H.; CHIEN-CHUAN CHEN; Chen M.-J.; Liou J.-M.; Liao W.-C.; Lai Y.-P.; Wang C.-P.; Ko J.-Y.; Wang H.-P.; Chiang H.; Lin J.-T.; Chen H.-H.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:56Z |
Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in high-risk patients: Yield rate, completion rate, and safety
|
Wang C.-H.; Lee Y.-C.; Wang C.-P.; CHIEN-CHUAN CHEN; Ko J.-Y.; Han M.-L.; Chen T.-C.; Lou P.-J.; Yang T.-L.; Hsiao T.-Y.; Wu M.-S.; Wang H.-P.; Tseng P.-H. |
| 臺大學術典藏 |
2022-02-18T08:46:55Z |
Performance of a one-step fecal sample-based test for diagnosis of Helicobacter pylori infection in primary care and mass screening settings
|
Lee Y.-C.; Tseng P.-H.; Liou J.-M.; Chen M.-J.; CHIEN-CHUAN CHEN; Tu C.-H.; Chiang T.-H.; Chiu H.-M.; Lai C.-F.; Ho J.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:55Z |
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
|
Chang L.-C.; Chiu H.-M.; Shun C.-T.; Liang J.-T.; Lin J.-T.; CHIEN-CHUAN CHEN; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:54Z |
Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population
|
Hung C.-S.; Tseng P.-H.; Tu C.-H.; CHIEN-CHUAN CHEN; Liao W.-C.; Lee Y.-C.; Chiu H.-M.; Lin H.-J.; Ho Y.-L.; Yang W.-S.; Wu M.-S.; Chen M.-F. |
| 臺大學術典藏 |
2022-02-18T08:46:52Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; CHIEN-CHUAN CHEN; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:52Z |
Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection
|
Chen M.-J.; Liou J.-M.; CHIEN-CHUAN CHEN; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:50Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; CHIEN-CHUAN CHEN; Chang C.-Y.; Chen M.-J.; CHIEN-CHUAN CHEN; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:46:50Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEN-CHUAN CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEN-CHUAN CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:46:49Z |
Muscular thickness of lower esophageal sphincter and therapeutic outcomes in achalasia: A prospective study using high-frequency endoscopic ultrasound
|
Li S.-W.; Tseng P.-H.; CHIEN-CHUAN CHEN; Liao W.-C.; Liu K.-L.; Lee J.-M.; Lee Y.-C.; Chuah S.-K.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-18T08:46:48Z |
Increased pancreatic echogenicity with Us: Relationship to glycemic progression and incident diabetes
|
Hung C.-S.; Tseng P.-H.; Tu C.-H.; CHIEN-CHUAN CHEN; Liao W.-C.; Lee Y.-C.; Chiu H.-M.; Lin H.-J.; Yang W.-S.; Chen M.-F.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:46Z |
Normative values and factors affecting water-perfused esophageal high-resolution impedance manometry for a Chinese population
|
Tseng P.-H.; Wong R.K.M.; Wu J.-F.; CHIEN-CHUAN CHEN; Tu C.-H.; Lee Y.-C.; Lee H.-C.; Wang H.-P.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:46:45Z |
Etiologies and clinical characteristics of non-obstructive dysphagia in a Taiwanese population: A prospective study based on high-resolution impedance manometry
|
Yeh C.-C.; CHIEN-CHUAN CHEN; Wu J.-F.; Lee H.-C.; Lee Y.-C.; Liu K.-L.; Wang H.-P.; Wu M.-S.; Tseng P.-H. |
| 臺大學術典藏 |
2022-02-18T08:46:44Z |
Early timing of single balloon enteroscopy is associated with increased diagnostic yield in patients with overt small bowel bleeding
|
Tu C.-H.; Kao J.Y.; Tseng P.-H.; Lee Y.-C.; Chiang T.-H.; CHIEN-CHUAN CHEN; Wang H.-P.; Chiu H.-M.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:26:09Z |
Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter
|
Han M.-L.; Lee Y.-C.; CHIEH-CHANG CHEN; Fang Y.-J.; Lee J.-Y.; Lin T.-L.; Lin L.-W.; Tseng P.-H.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-18T08:26:08Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; CHIEH-CHANG CHEN; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-18T08:26:08Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chen M.-J.; CHIEH-CHANG CHEN; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:26:07Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; CHIEH-CHANG CHEN; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:26:06Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; CHIEH-CHANG CHEN; Lee Y.-C.; Chen M.-J.; CHIEH-CHANG CHEN; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:26:05Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; CHIEH-CHANG CHEN; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:26:04Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; CHIEH-CHANG CHEN; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; CHIEH-CHANG CHEN; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:26:02Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:26:01Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; CHIEH-CHANG CHEN; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; CHIEH-CHANG CHEN; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T08:25:55Z |
Screening and eradication of Helicobacter pylori for gastric cancer prevention: The Taipei global consensus
|
Liou J.-M.; Malfertheiner P.; Lee Y.-C.; Sheu B.-S.; Sugano K.; Cheng H.-C.; Yeoh K.-G.; Hsu P.-I.; Goh K.-L.; Mahachai V.; Gotoda T.; Chang W.-L.; Chen M.-J.; Chiang T.-H.; CHIEH-CHANG CHEN; Wu C.-Y.; Leow A.H.-R.; Wu J.-Y.; Wu D.-C.; Hong T.-C.; Lu H.; Yamaoka Y.; Megraud F.; Chan F.K.L.; Sung J.J.Y.; Lin J.-T.; Graham D.Y.; Wu M.-S.; El-Omar E.M. |
| 臺大學術典藏 |
2022-02-18T08:25:54Z |
The interplay between Helicobacter pylori and gastrointestinal microbiota
|
CHIEH-CHANG CHEN; Liou J.-M.; Lee Y.-C.; Hong T.-C.; El-Omar E.M.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:25:54Z |
Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery
|
Wu W.-K.; Panyod S.; Liu P.-Y.; CHIEH-CHANG CHEN; Kao H.-L.; Chuang H.-L.; Chen Y.-H.; Zou H.-B.; Kuo H.-C.; Kuo C.-H.; Liao B.-Y.; Chiu T.H.T.; Chung C.-H.; Lin A.Y.-C.; Lee Y.-C.; Tang S.-L.; Wang J.-T.; Wu Y.-W.; Hsu C.-C.; Sheen L.-Y.; Orekhov A.N.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T08:25:53Z |
Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study
|
Chiang T.-H.; CHIEH-CHANG CHEN; Tseng P.-H.; Liou J.-M.; Wu M.-S.; Shun C.-T.; Lee Y.-C.; Graham D.Y. |
| 臺大學術典藏 |
2022-02-18T06:28:59Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; WEN-FENG HSU; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T06:28:59Z |
Effects of Metabolic Syndrome and Findings From Baseline Colonoscopies on Occurrence of Colorectal Neoplasms
|
Chiu H.-M.; Lee Y.-C.; Tu C.-H.; Chang L.-C.; WEN-FENG HSU; Chou C.-K.; Tsai K.-F.; Liang J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-18T06:28:58Z |
Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: Analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program
|
Chiu S.Y.-H.; Chuang S.-L.; Chen S.L.-S.; Yen A.M.-F.; Fann J.C.-Y.; Chang D.-C.; Lee Y.-C.; Wu M.-S.; Chou C.-K.; WEN-FENG HSU; Chiou S.-T.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:58Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; WEN-FENG HSU; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T06:28:56Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T06:28:55Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; WEN-FENG HSU; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-18T06:28:55Z |
Rolling-out Screening Volume Affecting Compliance Rate and Waiting Time of FIT-based Colonoscopy
|
Jen H.-H.; Hsu C.-Y.; Chen S.L.-S.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Lee Y.-C.; Wu M.-S.; WEN-FENG HSU; Peng S.-M.; Chen H.-H.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:54Z |
Time to Colonoscopy and Risk of Colorectal Cancer in Patients With Positive Results From Fecal Immunochemical Tests
|
Lee Y.-C.; Fann J.C.-Y.; Chiang T.-H.; Chuang S.-L.; Chen S.L.-S.; Chiu H.-M.; Yen A.M.-F.; Chiu S.Y.-H.; Hsu C.-Y.; WEN-FENG HSU; Wu M.-S.; Chen H.-H. |
| 臺大學術典藏 |
2022-02-18T06:28:54Z |
Effects of screening and universal healthcare on long-term colorectal cancer mortality
|
Lee Y.-C.; Hsu C.-Y.; Chen S.L.-S.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Chuang S.-L.; WEN-FENG HSU; Chiang T.-H.; Chiu H.-M.; Wu M.-S.; Chen H.-H. |
| 臺大學術典藏 |
2022-02-18T06:28:53Z |
The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management
|
Onyoh E.F.; WEN-FENG HSU; Chang L.-C.; Lee Y.-C.; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:51Z |
Risk of colonoscopy-related complications in a fecal immunochemical test-based population colorectal cancer screening program
|
WEN-FENG HSU; Chang C.-Y.; Chang C.-C.; Chang L.-C.; Chen C.-H.; Lin C.-C.; Lin Y.-M.; Lee C.-L.; Wu H.-Y.; Lee H.-C.; Lee Y.-C.; Su M.-Y.; Lin L.-J.; Chia S.-L.; Wu M.-S.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:51Z |
Classifying interval cancers as false negatives or newly occurring in fecal immunochemical testing
|
WEN-FENG HSU; Hsu C.-Y.; Yen A.M.-F.; Chen S.L.-S.; Chiu S.Y.-H.; Fann J.C.-Y.; Lee Y.-C.; Chiu H.-M.; Chen H.-H. |
| 臺大學術典藏 |
2022-02-18T06:28:50Z |
Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme
|
Peng S.-M.; WEN-FENG HSU; Wang Y.-W.; Lin L.-J.; Yen A.M.-F.; Chen L.-S.; Lee Y.-C.; Wu M.-S.; Chen T.H.-H.; Chiu H.-M. |
| 臺大學術典藏 |
2022-02-18T06:28:49Z |
Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers
|
Chiu H.-M.; Jen G.H.-H.; Wang Y.-W.; Fann J.C.-Y.; Hsu C.-Y.; Jeng Y.-C.; Yen A.M.-F.; Chiu S.Y.-H.; Chen S.L.-S.; WEN-FENG HSU; Lee Y.-C.; Wu M.-S.; Wu C.-Y.; Jou Y.-Y.; Chen T.H.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter
|
Han M.-L.; Lee Y.-C.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Lin T.-L.; Lin L.-W.; Tseng P.-H.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-14T06:28:53Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; YU-JEN FANG; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:52Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
